arrow
Z

Zhenduo Lu

Henan Cancer Hospital
H指数:13
被引数:336

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015)

新辅助抗HER2抗体偶联药物SHR-A1811在激素受体阳性、HER2低表达乳腺癌中的研究:一项II期临床试验(HELEN-015)

2026-08-310
OA
(Neo)adjuvant therapy patterns and outcomes in patients with HR+/HER2+ early breast cancer: a real-world study using the national cancer information database in China

新辅助/辅助治疗模式与预后在激素受体阳性/人表皮生长因子受体2阳性早期乳腺癌患者中的表现:一项基于中国国家癌症信息数据库的真实世界研究

2026-06-250
PRE
Neoadjuvant docetaxel plus cisplatin versus docetaxel plus doxorubicin and cyclophosphamide in early-stage triple-negative breast cancer (HNBC-001): results from a multicenter, randomized controlled, open-label phase II trial
2024-05-020
PRE
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
2021-04-2910
OAAI